Our top pick for
Koninklijke Philips N.V is a diagnostics & research business based in the US. Koninklijke Philips N-V shares (PHG) are listed on the NYSE and all prices are listed in US Dollars. Koninklijke Philips N-V employs 81,592 staff and has a market cap (total outstanding shares value) of 0.00.
|52-week range||$29.25 - $58.41|
|50-day moving average||$55.96|
|200-day moving average||$51.79|
|Wall St. target price||$60.75|
|Dividend yield||$0.932 (1.7%)|
|Earnings per share (TTM)||$1.58|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Koninklijke Philips N-V stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Koninklijke Philips N-V's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Koninklijke Philips N-V's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Koninklijke Philips N-V shares trade at around 36x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Koninklijke Philips N-V's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.6468. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Koninklijke Philips N-V's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Gross profit TTM||$8.8 billion|
|Return on assets TTM||4.21%|
|Return on equity TTM||9.83%|
|Market capitalisation||$51.1 billion|
TTM: trailing 12 months
There are currently 1.5 million Koninklijke Philips N-V shares held short by investors – that's known as Koninklijke Philips N-V's "short interest". This figure is 10.7% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting Koninklijke Philips N-V shares can be evaluated.
Koninklijke Philips N-V's "short interest ratio" (SIR) is the quantity of Koninklijke Philips N-V shares currently shorted divided by the average quantity of Koninklijke Philips N-V shares traded daily (recently around 423757.50708215). Koninklijke Philips N-V's SIR currently stands at 3.53. In other words for every 100,000 Koninklijke Philips N-V shares traded daily on the market, roughly 3530 shares are currently held short.
However Koninklijke Philips N-V's short interest can also be evaluated against the total number of Koninklijke Philips N-V shares, or, against the total number of tradable Koninklijke Philips N-V shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Koninklijke Philips N-V's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Koninklijke Philips N-V shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Koninklijke Philips N-V shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Koninklijke Philips N-V.
Find out more about how you can short Koninklijke Philips N-V stock.
Dividend payout ratio: 128.25% of net profits
Recently Koninklijke Philips N-V has paid out, on average, around 128.25% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.88% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Koninklijke Philips N-V shareholders could enjoy a 1.88% return on their shares, in the form of dividend payments. In Koninklijke Philips N-V's case, that would currently equate to about $0.932 per share.
Koninklijke Philips N-V's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Koninklijke Philips N-V's most recent dividend payout was on 8 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 May 2021 (the "ex-dividend date").
Koninklijke Philips N-V's shares were split on 29 June 2020.
Over the last 12 months, Koninklijke Philips N-V's shares have ranged in value from as little as $29.2455 up to $58.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Koninklijke Philips N-V's is 0.6868. This would suggest that Koninklijke Philips N-V's shares are less volatile than average (for this exchange).
Koninklijke Philips N. V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation, and patient management solutions; data, analytics, and actionable workflow solutions; and connected care informatics solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; male grooming and beauty products and solutions; and kitchen appliances, home care, and garment care products, as well as coffee machines.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.